We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.95%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$193B
AUM Growth
+$9.98B
Cap. Flow
+$5.76B
Cap. Flow %
2.98%
Top 10 Hldgs %
13.3%
Holding
8,497
New
756
Increased
3,610
Reduced
2,944
Closed
742

Sector Composition

Rank Sector Weight
1 Financials 7.75%
2 Healthcare 6.75%
3 Technology 6.26%
4 Industrials 5.06%
5 Consumer Discretionary 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSP
6526
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index
GSP
$14K ﹤0.01%
1,077
+902
+515% +$11.9K
MTL
6527
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$14K ﹤0.01%
2,972
+2,483
+508% +$12.9K
STLRU
6528
DELISTED
Stellar Acquisition III Inc. Units
STLRU
$14K ﹤0.01%
1,400
+100
+8% +$1.04K
BWV
6529
DELISTED
iPath ETN linked to CBOE S&P 500 Buy Write Index
BWV
$14K ﹤0.01%
197
+146
+286% +$10.7K
AKTX
6530
Akari Therapeutics
AKTX
$13.8M
$13K ﹤0.01%
3
-3
-50% -$23.7K
ALT icon
6531
Altimmune
ALT
$552M
$13K ﹤0.01%
132
+10
+8% +$1.66K
ASRV icon
6532
AmeriServ Financial
ASRV
$77.5M
$13K ﹤0.01%
3,129
AWX icon
6533
Avalon Holdings
AWX
$9.98M
$13K ﹤0.01%
5,400
-3,382
-39% -$8.4K
CKX icon
6534
CKX Lands
CKX
$13K ﹤0.01%
1,091
+1,058
+3,206% +$12.6K
CRK icon
6535
Comstock Resources
CRK
$3.89B
$13K ﹤0.01%
1,869
+1,868
+186,800% +$14.9K
DBVT
6536
DBV Technologies
DBVT
$799M
$13K ﹤0.01%
37
+28
+311% +$9.56K
EQBK icon
6537
Equity Bancshares
EQBK
$1.04B
$13K ﹤0.01%
422
-1,251
-75% -$38.7K
GCO icon
6538
Genesco
GCO
$425M
$13K ﹤0.01%
396
+16
+4% +$714
HHS icon
6539
Harte-Hanks
HHS
$16.2M
$13K ﹤0.01%
1,273
+1,266
+18,086% +$16K
JVA icon
6540
Coffee Holding Co
JVA
$19.5M
$13K ﹤0.01%
2,920
+263
+10% +$1.23K
LGMK
6541
DELISTED
LogicMark
LGMK
$13K ﹤0.01%
+1
New +$8.26K
MIND icon
6542
MIND Technology
MIND
$45.3M
$13K ﹤0.01%
323
-42
-12% -$1.84K
OOMA icon
6543
Ooma
OOMA
$598M
$13K ﹤0.01%
1,611
+611
+61% +$6.23K
DCOY
6544
Decoy Therapeutics
DCOY
$2.19M
0
SRI icon
6545
Stoneridge
SRI
$195M
$13K ﹤0.01%
838
+32
+4% +$536
XYLO
6546
DELISTED
Xylo Technologies
XYLO
$13K ﹤0.01%
+37
New +$14.8K
SYRS
6547
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$13K ﹤0.01%
81
+3
+4% +$471
RVNC
6548
DELISTED
Revance Therapeutics, Inc.
RVNC
$13K ﹤0.01%
511
+500
+4,545% +$11.1K
CMLS
6549
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$13K ﹤0.01%
28,648
+11,148
+64% +$4.26K
SVVC
6550
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
$13K ﹤0.01%
1,549
-398
-20% -$3.32K

Similar funds

UBS Group's Q2 2017 Portfolio in Review

As of Q2 2017, UBS Group held 8,497 positions worth $193B, up 5.4% from $183B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2017 filing shows 756 new, 3,610 increased, 2,944 reduced and 742 closed positions. Its largest new stake was Ultra Petroleum Corp. Common Stock: 3,128,785 shares worth $33.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.06B.

By sector, the portfolio is most concentrated in Financials at 7.7% of assets, up from 7.4% a quarter earlier, followed by Healthcare and Technology.

  • UBS Group's largest Q2 2017 buy was Ultra Petroleum Corp. Common Stock: 3,128,785 shares worth $33.9M.
  • UBS Group added most to Monsanto Co in Q2 2017, an estimated $622M increase.
  • UBS Group's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.06B.
  • UBS Group fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $383M.
  • UBS Group's ten largest holdings make up 13% of its $193B portfolio in Q2 2017.
  • UBS Group opened 756 new positions and closed 742 in Q2 2017.
  • UBS Group's portfolio value rose 5.4% quarter-over-quarter to $193B.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.